Royalty Pharma plc
RPRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001802768
In the last 90 days, Royalty Pharma plc insiders filed 0 open-market purchases and 4 sales; 650 institutions reported holding it in 13F filings for Q2 2026, worth $20.6B in total; Dorsey Asset Management is the only superinvestor holding it.
Q4 2025 vs. Q3 2025
How the institutions holding Royalty Pharma plc changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 490 | 6 | 542 | +58 |
| Shares | 328.9M | 127.0K | 357.9M | +29.1M (+8.9%) |
| Value | $11.6B | $4.48M | $13.8B | +$2.22B (+19.2%) |
6 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (108)
Institutions that held Royalty Pharma plc at the end of Q4 2025 but not at the end of Q3 2025.
Showing the largest 100 of 108 by value.
Sold out (50)
Institutions that held Royalty Pharma plc at the end of Q3 2025 and filed for Q4 2025 without it.
Not filed for Q4 2025 yet (6)
Institutions that held Royalty Pharma plc at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Synovus Financial Corp | 80,581 | $2.84M |
| AXA Investment Managers S.A. | 24,350 | $859.1K |
| CIBC Bancorp USA Inc. | 13,598 | $479.7K |
| Ridgewood Investments LLC | 8,397 | $296.2K |
| Pineridge Advisors LLC | 88 | $3.10K |
| Binnacle Investments Inc | 24 | $847 |